Andrew Henderson

2.9k total citations · 1 hit paper
31 papers, 1.9k citations indexed

About

Andrew Henderson is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Andrew Henderson has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Andrew Henderson's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Andrew Henderson is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Andrew Henderson collaborates with scholars based in United Kingdom, Australia and United States. Andrew Henderson's co-authors include Michael Barnett, John W. Prineas, John Parratt, Steve Vucic, Sudarshini Ramanathan, Russell C. Dale, Stephen Reddel, Fabienne Brilot, Vera Merheb and Esther Tantsis and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Brain.

In The Last Decade

Andrew Henderson

30 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

2017 390 citations Sudarshini Ramanathan, Shekeeb S. Mohammad et al. Journal of Neurology Neurosurgery & Psychiatry profile →

Peers

Countries citing papers authored by Andrew Henderson

Since Specialization

Citations

This map shows the geographic impact of Andrew Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Henderson more than expected).

Fields of papers citing papers by Andrew Henderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Henderson. The network helps show where Andrew Henderson may publish in the future.

Co-authorship network of co-authors of Andrew Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Henderson. A scholar is included among the top collaborators of Andrew Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Henderson. Andrew Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uveitis and optic perineuritis in the context of myelin oligodendrocyte glycoprotein antibody seropositivity 2019 ·European Journal of Neurology ·Sudarshini Ramanathan, Clare L. Fraser, (unknown), (unknown), Richard J. Leventer, Jeannette Lechner‐Scott, Andrew Henderson, Stephen Reddel, Russell C. Dale, Fabienne Brilot	22
2	032 Neurological sequelae of immune checkpoint inhibitors: a case series 2018 ·Journal of Neurology Neurosurgery & Psychiatry ·Matthew Silsby, (unknown), Neil Mahant, Steve Vucic, Andrew Henderson	0
3	Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination breakdown → 2017 ·Journal of Neurology Neurosurgery & Psychiatry ·Sudarshini Ramanathan, Shekeeb S. Mohammad, Esther Tantsis, Tina K. Nguyen, Vera Merheb, Victor S.C. Fung, Owen White, Simon Broadley, Jeannette Lechner‐Scott, Steve Vucic, Andrew Henderson, Michael Barnett, Stephen Reddel, Fabienne Brilot, Russell C. Dale	390
4	A robust and reproducible human pluripotent stem cell derived model of neurite outgrowth in a three-dimensional culture system and its application to study neurite inhibition 2016 ·Neurochemistry International ·(unknown), (unknown), Andrew Henderson, Mathilde Roger, Andrew Whiting, Stefan Przyborski	11
5	Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis 2015 ·Multiple Sclerosis Journal ·Sudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, Esther Tantsis, Stephen Reddel, Andrew Henderson, Steve Vucic, Mark Gorman, Leslie Benson, Gülay Alper, Catherine J. Riney, Michael Barnett, John Parratt, Todd A. Hardy, Richard J. Leventer, Vera Merheb, Margherita Nosadini, Victor SC Fung, Fabienne Brilot, Russell C. Dale	248
6	Successful treatment of Cryptococcus neoformans immune reconstitution inflammatory syndrome in an immunocompetent host using thalidomide 2014 ·Medical Mycology Case Reports ·(unknown), Andrew Henderson, Sharon C.-A. Chen, Jen Kok	15
7	The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease 2014 ·Clinical Immunology ·Grant P. Parnell, Prudence N. Gatt, Małgorzata Krupa, Dorothee Nickles, Fiona C. McKay, Stephen D. Schibeci, Marcel Batten, Sergio E. Baranzini, Andrew Henderson, Michael Barnett, Mark Slee, Steve Vucic, Graeme J. Stewart, David R. Booth	44
8	Design and biological evaluation of synthetic retinoids: probing length vs. stability vs. activity 2013 ·Molecular BioSystems ·Graeme Clemens, Kevin R. Flower, Peter Gardner, Andrew Henderson, Jonathan P. Knowles, Todd B. Marder, Andrew Whiting, Stefan Przyborski	21
9	The action of all- trans -retinoic acid (ATRA) and synthetic retinoid analogues (EC19 and EC23) on human pluripotent stem cells differentiation investigated using single cell infrared microspectroscopy 2013 ·Molecular BioSystems ·Graeme Clemens, Kevin R. Flower, Andrew Henderson, Andrew Whiting, Stefan Przyborski, (unknown), (unknown), Paul Bassan, Gianfelice Cinque, Peter Gardner	28
10	Early factors associated with axonal loss after optic neuritis 2011 ·Annals of Neurology ·Andrew Henderson, Daniel R. Altmann, S. Anand Trip, Katherine Miszkiel, Patricio G. Schlottmann, (unknown), David F. Garway‐Heath, Gordon T. Plant, David H. Miller	39
11	Novel Silicon‐Containing Analogues of the Retinoid Agonist Bexarotene: Syntheses and Biological Effects on Human Pluripotent Stem Cells 2011 ·ChemMedChem ·(unknown), (unknown), (unknown), (unknown), Christian Burschka, (unknown), (unknown), Andrew Henderson, (unknown), Todd B. Marder, Stefan Przyborski, Reinhold Tacke	22
12	A method for measuring the cross sectional area of the anterior portion of the optic nerve in vivo using a fast 3D MRI sequence 2010 ·Journal of Magnetic Resonance Imaging ·Marios Yiannakas, Claudia A. M. Gandini Wheeler‐Kingshott, (unknown), Karyn E. Chappell, Andrew Henderson, Madhan Kolappan, David H. Miller, Daniel J. Tozer	12
13	A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis 2010 ·Journal of Neurology ·Andrew Henderson, S. Anand Trip, Patricio G. Schlottmann, D. R. Altmann, David F. Garway‐Heath, G. T. Plant, David H. Miller	53
14	Retinoid supplementation of differentiating human neural progenitors and embryonic stem cells leads to enhanced neurogenesis in vitro 2010 ·Journal of Neuroscience Methods ·(unknown), Daniel J. Maltman, Andrew Henderson, Andrew Whiting, Todd B. Marder, Majlinda Lako, Stefan Przyborski	22
15	A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials 2010 ·Brain ·Andrew Henderson, Daniel R. Altmann, Anand Trip, Constantinos Kallis, (unknown), Patricio G. Schlottmann, David F. Garway‐Heath, Gordon T. Plant, David H. Miller	96
16	Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions 2009 ·Annals of Neurology ·Andrew Henderson, Michael Barnett, John Parratt, John W. Prineas	289
17	A New Approach to the Synthesis of 4-Hydroxyethylsulfonylstyrene 2009 ·Organic Process Research & Development ·Christophe Grosjean, Andrew Henderson, Damien Hérault, Gennadiy Ilyashenko, Jonathan P. Knowles, Andrew Whiting, A.R. Wright	5
18	Neuroplasticity predicts outcome of optic neuritis independent of tissue damage 2009 ·Annals of Neurology ·Thomas M. Jenkins, Ahmed Toosy, Olga Ciccarelli, Katherine Miszkiel, Claudia A. M. Gandini Wheeler‐Kingshott, Andrew Henderson, Constantinos Kallis, Laura Mancini, Gordon T. Plant, David H. Miller, Alan J. Thompson	64
19	Searching for Cyclin-Dependent Kinase Inhibitors Using a New Variant of the Cope Elimination 2006 ·Journal of the American Chemical Society ·Roger J. Griffin, Andrew Henderson, Nicola J. Curtin, Aude Echalier, Jane Endicott, Ian R. Hardcastle, David R. Newell, M.E.M. Noble, Lan-Zhen Wang, Bernard T. Golding	65
20	Facilitation of addition–elimination reactions in pyrimidines and purines using trifluoroacetic acid in trifluoroethanol 2003 ·Chemical Communications ·(unknown), Roger J. Griffin, Ian R. Hardcastle, Andrew Henderson, (unknown), Véronique Mesguiche, Kerry L. Sayle, Bernard T. Golding	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact